Karen Bonham
Tracked across 1 events · 21 articles · First seen May 29, 2026 · Last active Jun 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Karen Bonham, a patient in the OPTIMA trial, avoided chemotherapy due to a low Prosigna score, highlighting the personal benefits of the test and providing a positive patient testimonial.
May 29, 2026 · 21 articles
ERGEN INTELLIGENCE
Track Karen Bonham live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard